Emil Kazounis
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study.
Journal: IJTLD open
Published: December 19, 2025
How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL clinical trial.
Journal: Antimicrobial agents and chemotherapy
Published: June 06, 2024
Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens.
Journal: PLOS global public health
Published: May 27, 2024
24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation.
Journal: The Lancet. Global health
Published: January 05, 2024
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Journal: The Lancet. Respiratory medicine
Published: September 01, 2023
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Journal: The New England journal of medicine
Published: December 22, 2022
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.
Journal: PLOS global public health
Published: August 17, 2022
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Journal: Trials
Published: November 25, 2021
Optimising recruitment to a late-phase tuberculosis clinical trial: a qualitative study exploring patient and practitioner experiences in Uzbekistan.
Journal: Trials
Published: January 25, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026